BCL2 and cancer: Besides Bcl-2, other members of the apoptotic pathways, such as Bcl-XL have been found to be oncogenic drivers in colorectal cancer, while Bax, yet another member, has been inactivated in some other cancers, such as colon cancer and hematopoietic malignancies [39,40].